International Trends in Lithium Use for Pharmacotherapy and Clinical Correlates in Bipolar Disorder: A Scoping Review

Yao Kang Shuy,Sanjana Santharan,Qian Hui Chew,Kang Sim
DOI: https://doi.org/10.3390/brainsci14010102
IF: 3.333
2024-01-21
Brain Sciences
Abstract:Lithium remains an effective option in the treatment of bipolar disorder (BD). Thus, we aim to characterize the pharmaco-epidemiological patterns of lithium use internationally over time and elucidate clinical correlates associated with BD using a scoping review, which was conducted using the methodological framework by Arksey and O'Malley (2005). We searched several databases for studies that examined the prescriptions for lithium and clinical associations in BD from inception until December 2023. This review included 55 articles from 1967 to 2023, which collected data from North America (n = 24, 43.6%), Europe (n = 20, 36.4%), and Asia (n = 11, 20.0%). The overall prescription rates ranged from 3.3% to 84% (33.4% before and 30.6% after the median year cutoffs). Over time, there was a decline in lithium use in North America (27.7% before 2010 to 17.1% after 2010) and Europe (36.7% before 2003 to 35.7% after 2003), and a mild increase in Asia (25.0% before 2003 to 26.2% after 2003). Lithium use was associated with specific demographic (e.g., age, male gender) and clinical factors (e.g., lower suicide risk). Overall, we found a trend of declining lithium use internationally, particularly in the West. Specific clinical correlates can support clinical decision-making for continued lithium use.
neurosciences
What problem does this paper attempt to address?
This paper aims to explore the international trends in the use of lithium salts in the treatment of Bipolar Disorder (BD) and its clinical correlates. Specifically, the study objectives include: 1. **Describe the prescription rates of lithium salts in different regions and over time**: Through retrospective analysis, understand the usage of lithium salts in North America, Europe, and Asia and their changing trends over time. 2. **Identify clinical factors associated with the use of lithium salts**: Investigate the sociodemographic characteristics (such as age, gender), treatment settings (inpatient or outpatient), disease characteristics (such as suicide risk), and other clinical factors related to the use of lithium salts. ### Research Background Bipolar Disorder is a mood disorder characterized by fluctuations between elevated and depressed moods. Lithium salts, as an effective long-term treatment, have been widely used in the treatment of Bipolar Disorder since their introduction in 1949. However, in recent years, the prescription rate of lithium salts has declined, raising concerns about the trends in lithium use and its clinical impact. ### Research Methods This study adopts the five-step framework for scoping reviews proposed by Arksey and O’Malley (2005), which includes: 1. **Identifying the main research question**: The prescription rates of lithium salts in Bipolar Disorder and their clinical correlates. 2. **Identifying relevant studies**: Searching multiple databases (such as PubMed, Medline, and Scopus) for relevant studies from the inception of the databases to October 2023. 3. **Study selection**: Screening studies based on inclusion and exclusion criteria to identify eligible studies. 4. **Data extraction**: Extracting detailed information from the studies, including authors, study year, country, study design, sample size, mean age, gender ratio, treatment setting, main findings, etc. 5. **Collating and reporting results**: Summarizing the main characteristics of all included studies and conducting statistical analysis. ### Main Findings 1. **Overall Trends**: The prescription rate of lithium salts shows a declining trend internationally, especially in Western countries. For example, the prescription rate of lithium salts in North America decreased from 27.7% before 2010 to 17.1% after 2010, while in Europe, it decreased from 36.7% before 2003 to 35.7% after 2003. In Asia, the prescription rate of lithium salts slightly increased from 25.0% before 2003 to 26.2% after 2003. 2. **Clinical Correlates**: The use of lithium salts is associated with specific demographic characteristics (such as older age, male gender) and clinical factors (such as lower suicide risk). Additionally, lithium salts have shown some effectiveness in reducing psychiatric hospitalization rates and cancer risk. ### Conclusion Despite the significant effectiveness of lithium salts in the treatment of Bipolar Disorder, their prescription rate is declining globally. Understanding these trends and their underlying clinical correlates can help guide clinicians in better utilizing lithium salts in treatment decisions.